Dr. Basil Mantas Paulus, MD

Dr. Paulus practices at Baptist Memorial Hospital-Memphis in Memphis, Tennessee, part of Baptist Memorial Health Care.

Dr. Paulus' NPI, 1073731592, was assigned on April 22, 2007. Dr. Paulus holds Mississippi license 43843.

Dr. Paulus' primary practice is Baptist Memorial Hospital-Memphis, at 6019 Walnut Grove Road, Memphis, TN 38120 in Shelby County. The practice phone is (901) 226-5000.

Dr. Paulus' primary practice is Baptist Memorial Hospital-Memphis in Memphis, Tennessee, part of Baptist Memorial Health Care. Dr. Paulus is also affiliated with Methodist University Hospital. The medical group on file is NEA Baptist Clinic. Dmand AI also links Dr. Paulus to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paulus practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Paulus' primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Paulus is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Paulus is licensed in Mississippi.

CMS data shows 3,642 Medicare services from Dr. Paulus across 27 procedure codes in 2024, for 1,123 Medicare patients. Medicare paid $290,073 for them.

CMS counts 1,123 Medicare patients who saw Dr. Paulus in 2024. The largest group is 75 to 84, with 465 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Paulus' median patient age at 73, with 49% women.

In 2024, Dr. Paulus wrote 3,556 Medicare Part D claims for 468 patients. 84% of them were for generic drugs. CMS names the drug for 3,264 of them, across 51 drugs with 11 or more claims each, at $550,088 in total drug cost. In 2023, CMS named 2,980 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Paulus for performance year 2024, reported as part of a group. Dr. Paulus accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of coronary angioplasty and stenting by Dr. Paulus, more than 52% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Paulus, published from 2014 to 2024. Dr. Paulus' most frequent co-authors are Sheriff Nii Ofei Dodoo, MD, Vishal Gupta, MD and Uzoma N. Ibebuogu, MD.

Dmand AI links Dr. Paulus to 6 clinical trials. 1 is still active or recruiting. Conditions studied include Coronary Artery Disease, Coronary Disease and Hemorrhage. Abbott Medical Devices sponsors the most, 2.

CMS Open Payments shows 1,155 general payments to Dr. Paulus from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 37% of the total. Edwards Lifesciences Corporation paid the most, $41,425.